internationalbadassactivists.org
FDA review finds no increased risk of prostate cancer with Parkinson’s disease medicines containing entacapone (Comtan, Stalevo) | FDA
FDA Drug Safety Communication Source: FDA review finds no increased risk of prostate cancer with Parkinson’s disease medicines containing entacapone (Comtan, Stalevo) | FDA